Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.
The investor pages that follow are your resource for financial information about Medivation, Inc.Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Recent ReleasesMay 11, 2012 EventsJun 5, 2012 Jun 13, 2012 Investor and Media Contacts
For Investors
For Media |
| Medivation © 2012 |